Simone Brefka

Simone Brefka

Auto-generated profile, based on publicly available information

Simone Brefka

Institute for Geriatric Research, Ulm University Medical Center, Ulm, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2022 in JMIR Aging
Verified
Journal Article
Open access
MFMarina Liselotte Fotteler
Marina Liselotte Fotteler
VMViktoria Mühlbauer
Viktoria Mühlbauer
SBSimone Brefka
Simone Brefka
SMSarah Mayer
Sarah Mayer
BKBrigitte Kohn
Brigitte Kohn
DDDhayana Dallmeier
Dhayana Dallmeier
Background: The use of assistive technologies (ATs) to support older people has been fueled by the demographic change and technological progress in many countries. These devices are designed to assist seniors, enable independent living at home or in residential facilities, and improve quality of life by addressing age-related difficulties. Objective: We aimed to evaluate the effectiveness of ATs on relevant outcomes with a focus on frail older adults. Methods: A systematic literature review of randomized controlled trials evaluating ATs was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The Ovid Medline, PsycINFO, SocIndex, CINAHL (Cumulative Index to Nursing and Allied Health Literature), CENTRAL (Cochrane Central Register of Controlled Trials), and IEEEXplore databases were searched from January 1, 2009, to March 15, 2019. ATs were included when aiming to support the domains autonomy, communication, or safety of older people with a mean age ≥65 years. Trials performed within a laboratory setting were excluded. Studies were retrospectively categorized according to the physical frailty status of participants. Results: A total of 19 trials with a high level of heterogeneity were included in the analysis. Six device categories were identified: mobility, personal disease management, medication, mental support, hearing, and vision. Eight trials showed significant effectiveness in all or some of the primary outcome measures. Personal disease management devices seem to be the most effective, with four out of five studies showing significant improvement of disease-related outcomes. Frailty could only be assessed for seven trials. Studies including participants with significant or severe impairment showed no effectiveness. Conclusions: Different ATs show some promising results in well-functioning but not in frail older adults, suggesting that the evaluated ATs might not (yet) be suitable for this subgroup. The uncertainty of the effectiveness of ATs and the lack of high-quality research for many promising supportive devices were confirmed in this systematic review. Large studies, also including frail older adults, and clear standards are needed in the future to guide professionals, older users, and their relatives. Trial Registration: PROSPERO CRD42019130249; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=130249

14 January 2022 in Zeitschrift für Gerontologie und Geriatrie
Verified
Journal Article
Open access
PDF file
SBSimone Brefka
Simone Brefka
GEGerhard Wilhelm Eschweiler
Gerhard Wilhelm Eschweiler
DDDhayana Dallmeier
Dhayana Dallmeier
MDMichael Denkinger
Michael Denkinger
CLChristoph Leinert
Christoph Leinert
Background: Delirium is a frequent psychopathological syndrome in geriatric patients. It is sometimes the only symptom of acute illness and bears a high risk for complications. Therefore, feasible assessments are needed for delirium detection. Objective and methods: Rapid review of available delirium assessments based on a current Medline search and cross-reference check with a special focus on those implemented in acute care hospital settings. Results: A total of 75 delirium detection tools were identified. Many focused on inattention as well as acute onset and/or fluctuating course of cognitive changes as key features for delirium. A range of assessments are based on the confusion assessment method (CAM) that has been adapted for various clinical settings. The need for a collateral history, time resources and staff training are major challenges in delirium assessment. Latest tests address these through a two-step approach, such as the ultrabrief (UB) CAM or by optional assessment of temporal aspects of cognitive changes (4 As test, 4AT). Most delirium screening assessments are validated for patient interviews, some are suitable for monitoring delirium symptoms over time or diagnosing delirium based on collateral history only. Conclusion: Besides the CAM the 4AT has become well-established in acute care because of its good psychometric properties and practicability. There are several other instruments extending and improving the possibilities of delirium detection in different clinical settings.

18 May 2022 in Zeitschrift für Gerontologie und Geriatrie
Verified
Journal Article
Open access
PDF file
SBSimone Brefka
Simone Brefka
GEGerhard Wilhelm Eschweiler
Gerhard Wilhelm Eschweiler
DDDhayana Dallmeier
Dhayana Dallmeier
MDMichael Denkinger
Michael Denkinger
CLChristoph Leinert
Christoph Leinert

17 October 2025 in JMIR Aging
Verified
Journal Article
Open access
NPNina Parchmann
Nina Parchmann
MOMarcin Orzechowski
Marcin Orzechowski
SBSimone Brefka
Simone Brefka
FSFlorian Steger
Florian Steger
Background: The development and introduction of an artificial intelligence (AI)–based clinical decision support system (CDSS) in surgical departments as part of the “Supporting Surgery with Geriatric Co-management and AI” project addresses the challenges of an increasingly aging population. The system enables digital comanagement of older patients by providing evidence-based evaluations of their health status, along with corresponding medical recommendations, with the aim of improving their perioperative care. Objective: The use of an AI-based CDSS in patient care raises ethical challenges. Gathering the opinions, expectations, and concerns of older adults (as potential patients) regarding the CDSS enables the identification of ethical opportunities, concerns, and limitations associated with implementing such a system in hospitals. Methods: We conducted 5 focus groups with participants aged 65 years or older. The transcripts were evaluated using qualitative content analysis and ethically analyzed. Categories were inductively generated, followed by a thematic classification of participants’ statements. We found that technical understanding did not influence the older adults’ opinions. Results: Ethical opportunities and concerns were identified. On the one hand, diagnosis and treatment could be accelerated, the patient-AI-physician interaction could enhance medical treatment, and the coordination of hospital processes could be improved. On the other hand, the quality of the CDSS depends on an adequate data foundation and robust cybersecurity. Potential risks included habituation effects, loss of a second medical opinion, and illness severity influencing patients’ attitude toward medical recommendations. The risk of overdiagnosis and overtreatment was discussed controversially, and treatment options could be influenced by interests and finances. Additional concerns included challenges with time savings, potential declines in medical skills, and effects on the length of hospital stay. Conclusions: To address the ethical challenges, we recommend allocating sufficient time for use of the CDSS and emphasizing individualized review of the CDSS results. Furthermore, we suggest limiting private financial sponsorship.

13 August 2025 in Sensors
Verified
Journal Article
Open access
PDF file
TKThomas Derya Kocar
Thomas Derya Kocar
SBSimone Brefka
Simone Brefka
CLChristoph Leinert
Christoph Leinert
URUtz Lovis Rieger
Utz Lovis Rieger
HKHans Kestler
Hans Kestler
MDMichael Denkinger
Michael Denkinger
The growing proportion of older adults in the population necessitates improved methods for assessing functional recovery. Objective, continuous monitoring using wearable sensors offers a promising alternative to traditional, often subjective assessments. This study aimed to investigate the utility of inertial measurement unit (IMU)-based data, combined with deep learning, to predict postoperative mobility, activities of daily living, and discharge destination in older adults following surgery. Data from the SURGE-Ahead project was analyzed, involving 39 patients (mean age 79.05 years) wearing lumbar IMU sensors for up to five postoperative days. Deep learning models (TabPFN) were applied and validated using leave-one-out cross-validation to predict the Charité Mobility Index (CHARMI), the Barthel Index, and discharge destination. The TabPFN model achieved R2 values of 0.65 and 0.70 for predicting CHARMI and Barthel Index scores, respectively, with moderate to strong agreement with human assessments (weighted kappa ≥ 0.80). Discharge destination was predicted with an accuracy of 82%. The z-channel IMU data and parameters related to walking bouts were most predictive of outcomes. IMU-based data, combined with deep learning, demonstrates potential for automated functional assessment and discharge decision support in older adults following surgery.

19 July 2021 in JMIR Preprints
Verified
Preprint
Open access
MFMarina Liselotte Fotteler
Marina Liselotte Fotteler
VMViktoria Mühlbauer
Viktoria Mühlbauer
SBSimone Brefka
Simone Brefka
SMSarah Mayer
Sarah Mayer
BKBrigitte Kohn
Brigitte Kohn
DDDhayana Dallmeier
Dhayana Dallmeier
BACKGROUND The use of assistive technologies (ATs) to support older people has been fueled by the demographic change and technological progress in many countries. These devices are designed to assist seniors, enable independent living at home or in residential facilities, and improve quality of life by addressing age-related difficulties. OBJECTIVE We aimed to evaluate the effectiveness of ATs on relevant outcomes with a focus on frail older adults. METHODS A systematic literature review of randomized controlled trials evaluating ATs was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The Ovid Medline, PsycINFO, SocIndex, CINAHL (Cumulative Index to Nursing and Allied Health Literature), CENTRAL (Cochrane Central Register of Controlled Trials), and IEEEXplore databases were searched from January 1, 2009, to March 15, 2019. ATs were included when aiming to support the domains autonomy, communication, or safety of older people with a mean age ≥65 years. Trials performed within a laboratory setting were excluded. Studies were retrospectively categorized according to the physical frailty status of participants. RESULTS A total of 19 trials with a high level of heterogeneity were included in the analysis. Six device categories were identified: mobility, personal disease management, medication, mental support, hearing, and vision. Eight trials showed significant effectiveness in all or some of the primary outcome measures. Personal disease management devices seem to be the most effective, with four out of five studies showing significant improvement of disease-related outcomes. Frailty could only be assessed for seven trials. Studies including participants with significant or severe impairment showed no effectiveness. CONCLUSIONS Different ATs show some promising results in well-functioning but not in frail older adults, suggesting that the evaluated ATs might not (yet) be suitable for this subgroup. The uncertainty of the effectiveness of ATs and the lack of high-quality research for many promising supportive devices were confirmed in this systematic review. Large studies, also including frail older adults, and clear standards are needed in the future to guide professionals, older users, and their relatives.